Skip to content

Contract award record

National Framework Agreement for the supply of Recombinant Factor VIII products for the treatment of bleeding disorders

Notice details

Published
Category
goods
Buyer region
North West

Public buyer and contract winner

Public buyer

NHS England
awarded to

Contract winner

Baxalta Limited

Award value£302,000,000

  1. Awarded
    Completed
  2. Start
    Completed
  3. End
    Completed

Work description

NHS framework agreement for the supply of Recombinant Factor VIII products for the treatment of bleeding disorders. The framework will commence on 1.2.2018 for a period of 12 months until 31.1.2019 with options to extend up to a further 17 months.

Related awards

Source: Contracts Finder · Notice 6bab93eb-e9a0-4819-a8d7-210a780e9a11-187830

View source notice